Table 2 The QALE (quality-adjusted life expectancy), loss-of-QALE, healthcare expenditures (in US dollars) of lung cancer patients
From: Estimating the lifelong health impact and financial burdens of different types of lung cancer
NSCLC (n = 59,787) | |||
|---|---|---|---|
SqCC (n = 16,796) | Adenocarcinoma (n = 33,669) | Other NSCLCs*(n = 9,322) | |
Age at diagnosis, mean (SD) years | 69.35 (10.63) | 65.60 (12.84) | 68.12 (12.11) |
Sex, no. of males (%) | 14,423 (85.87) | 18,075 (53.68) | 6,625 (71.07) |
Life expectancy, mean (SE) years | 2.73 (0.02) | 3.46 (0.02) | 1.99 (0.02) |
Expected years of life lost, mean (SE) years | 11.84 (0.03) | 14.61 (0.03) | 13.91 (0.03) |
QALE, mean (SE) QALY | 2.37 (0.05) | 3.03 (0.03) | 1.74 (0.07) |
Loss-of-QALE, mean (SE) QALY | |||
Assumed mean utility of referents = 1 | 12.22 (0.05) | 15.03 (0.04) | 14.17 (0.08) |
Assumed mean utility of referents = 0.95 | 11.45 (0.05) | 14.16 (0.03) | 13.35 (0.08) |
Assumed mean utility of referents = 0.9 | 10.75 (0.05) | 13.25 (0.04) | 12.58 (0.08) |
Lifetime healthcare expenditures per case, | |||
NHI-reimbursed medical costs, mean (SE) $ | 14,249 (1,435) | 18,150 (1,469) | 12,918 (1,156) |
Out-of-pocket medical costs, mean (SE) $ | 6,350 (741) | 18,620 (1,857) | 7,439 (842) |
Healthcare expenditures/life-year per case, mean (SE) $ | 9,281 (803) | 13,636 (754) | 12,546 (1,050) |
Healthcare expenditures/QALY per case, mean (SE) $ | 10,841 (980) | 15,642 (885) | 14,475 (1,400) |